Our data indicated that SREBP-1c protein expression, in addition to the expression of lipogenic target genes ACC1 and FAS and fatty acid oxidation gene CPT-1 were suppressed by swertiamarin in hLGC’s from PCOS-IR supported by [30, 43]. The gene discussed is FAS; the disease is polycystic ovary syndrome.